Amarantus.png
Amarantus Provides Update on Elto Pharma Capital Formation Plan
07 juin 2018 09h08 HE | Amarantus Bioscience Holdings, Inc.
NEW YORK, June 07, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire –  Amarantus Bioscience Holdings, Inc. (OTC Pink:AMBS) (the "Company," or AMBS), a US-based, JLABS-alumnus biotechnology holding...
Amarantus.png
Elto Pharma Receives Notice of Allowance in Canada for Patent Covering Use of Eltoprazine to Treat non-ADHD Cognitive Impairment
01 mai 2018 10h31 HE | Amarantus Bioscience Holdings, Inc.
NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Elto Pharma, Inc., a specialty pharmaceutical, clinical-stage wholly-owned subsidiary of Amarantus Bioscience Holdings, Inc....
Amarantus.png
Elto Pharma to Present and Participate in Neuroscience Panel at Sachs BioCapital USA Forum
05 mars 2018 08h00 HE | Amarantus Bioscience Holdings, Inc.
SAN FRANCISCO, March 05, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Elto Pharma, Inc., an orphan specialty pharmaceutical, clinical-stage wholly-owned subsidiary of Amarantus Bioscience Holdings,...